|
US2776926A
(en)
|
1955-08-04 |
1957-01-08 |
Eugene S Sharpe |
Preparation of alpha-ketoglutaric acid by serratia marcescens
|
|
US2917528A
(en)
|
1956-08-24 |
1959-12-15 |
Victor Chemical Works |
Alkanolaminealkanephosphonic acids and salts thereof
|
|
US2841616A
(en)
*
|
1956-10-30 |
1958-07-01 |
Campbell Soup Co |
Process for the recovery of alpha-ketoglutaric acid
|
|
US3875304A
(en)
|
1970-04-24 |
1975-04-01 |
Schlitz Brewing Co J |
Livestock feed composition and method of preparing the same
|
|
US4045585A
(en)
|
1976-05-19 |
1977-08-30 |
Decel Corporation |
Flavored animal food compositions
|
|
DE3151196A1
(de)
*
|
1981-12-23 |
1983-06-30 |
Kurt Heinz Prof. Dr. 7800 Freiburg Bauer |
Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen
|
|
US6451341B1
(en)
|
1990-02-05 |
2002-09-17 |
Thomas J. Slaga |
Time release formulation of vitamins, minerals and other beneficial supplements
|
|
US5646187A
(en)
|
1992-05-20 |
1997-07-08 |
Ab Erik Vinnars |
Use of alpha-ketoglutarate
|
|
US6306430B1
(en)
|
1998-04-16 |
2001-10-23 |
The Iams Company |
Process for decreasing adiposity using vitamin a as a dietary supplement
|
|
US6905707B2
(en)
|
1998-05-28 |
2005-06-14 |
Medical Research Institute |
Controlled release arginine alpha ketoglutarate
|
|
CO5140079A1
(es)
|
1998-10-14 |
2002-03-22 |
Novartis Ag |
Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
AU2002228955B2
(en)
|
2000-12-20 |
2005-09-29 |
Alcon Inc. |
Solution for removing cataracts via liquefracture
|
|
AU2004237437B2
(en)
*
|
2003-05-07 |
2011-01-20 |
Osteologix A/S |
Controlled release composition containing a strontium salt
|
|
US7589235B2
(en)
|
2004-05-06 |
2009-09-15 |
Osteologix, A/S |
High yield and rapid synthesis methods for producing metallo-organic salts
|
|
PL368572A1
(en)
|
2004-06-17 |
2005-12-27 |
Sgp & Sons Ab |
Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
|
|
EP1778616A1
(en)
|
2004-08-09 |
2007-05-02 |
Cancer Research Technology Limited |
Alpha-ketoglutarates and their use as therapeutic agents
|
|
DK1824470T3
(da)
|
2004-12-17 |
2014-08-18 |
Cash Alan Brian |
Fremgangsmåde til forlængelse af levetiden og forsinke starttidspunktet for alders-relateret sygdom
|
|
US20060234250A1
(en)
|
2005-04-15 |
2006-10-19 |
Powers Ralph W Iii |
Methods of screening and compositions for life span modulators
|
|
EP1915144A4
(en)
|
2005-06-20 |
2009-08-19 |
Accera Inc |
METHOD FOR REDUCING OXIDATIVE DAMAGE AND IMPROVING MITOCHONDRIA EFFICIENCY
|
|
WO2007053943A1
(en)
|
2005-11-08 |
2007-05-18 |
Multi Formulations Ltd. |
The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance
|
|
US8367121B2
(en)
|
2005-11-23 |
2013-02-05 |
Florida A & M University |
Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
|
|
PL379512A1
(pl)
|
2006-04-21 |
2007-10-29 |
Sgp & Sons Ab |
Nowe metody i ich zastosowanie
|
|
PL226695B1
(pl)
|
2006-07-03 |
2017-08-31 |
Danuta Kruszewska |
Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
|
|
JP2010522190A
(ja)
|
2007-03-19 |
2010-07-01 |
メタプロテオミクス， エルエルシー |
骨及び関節の健康を助成するための方法と組成物
|
|
MX2009013937A
(es)
|
2007-07-02 |
2010-04-30 |
Entress Ab |
Nuevo uso de compuestos quimicos farmacologicamente activos conocidos.
|
|
EP2033623A1
(en)
|
2007-09-07 |
2009-03-11 |
Cutech S.R.L. |
Compositions comprising ornithine ketoglutarate (OKG)
|
|
JP5406643B2
(ja)
|
2008-09-22 |
2014-02-05 |
日本合成化学工業株式会社 |
α−オキソカルボン酸の金属塩の製造方法
|
|
CN101759553A
(zh)
|
2008-11-21 |
2010-06-30 |
扬子江药业集团北京海燕药业有限公司 |
α-酮酸钙的制备方法
|
|
DE102009016119A1
(de)
|
2009-04-03 |
2010-10-14 |
Evonik Degussa Gmbh |
Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
|
|
BRPI1010655A2
(pt)
|
2009-04-10 |
2019-09-03 |
Qi Haiyan |
novos agentes antienvelhecimento e métodos para identificá-los
|
|
CN102481271A
(zh)
|
2009-05-11 |
2012-05-30 |
博格生物系统有限责任公司 |
利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法
|
|
EP3120709A1
(en)
|
2009-05-28 |
2017-01-25 |
IAMS Europe B.V. |
Pet food in the form of a coated kibble
|
|
EP2440212A4
(en)
|
2009-06-12 |
2013-03-20 |
Generex Pharm Inc |
COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CORONARY DISEASE
|
|
JP6159084B2
(ja)
|
2009-06-30 |
2017-07-05 |
デルマン バイオメディシン カンパニー リミテッド |
酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物
|
|
WO2011060305A1
(en)
|
2009-11-12 |
2011-05-19 |
Nox Technologies, Inc. |
Potato skin compositions that lower cytosolic nadh level to mimic calorie restriction
|
|
WO2012114204A2
(en)
|
2011-02-15 |
2012-08-30 |
Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto |
Methods of treating mitochondrial dysfunction
|
|
JP2014511890A
(ja)
|
2011-04-18 |
2014-05-19 |
ネステク ソシエテ アノニム |
α−ＨＩＣＡ及びα−ケトグルタル酸を含有する栄養組成物
|
|
WO2012174537A2
(en)
|
2011-06-16 |
2012-12-20 |
President And Fellows Of Harvard College |
Small molecule screening for mouse satellite cell proliferation
|
|
CN102586347B
(zh)
*
|
2012-03-06 |
2014-04-09 |
江南大学 |
一种两阶段pH控制高产a-酮戊二酸的方法
|
|
US9532997B2
(en)
|
2012-04-03 |
2017-01-03 |
Whitehead Institute For Biomedical Research |
Compositions and methods for promoting intestinal stem cell function
|
|
ITBO20120226A1
(it)
|
2012-04-24 |
2013-10-25 |
Alfa Wassermann Spa |
Composizioni comprendenti ornitina alfa-chetoglutarato, processi per il loro ottenimento e il loro uso.
|
|
JP6029058B2
(ja)
|
2012-09-14 |
2016-11-24 |
国立研究開発法人農業・食品産業技術総合研究機構 |
シュウ酸カルシウムを含む氷核活性剤
|
|
CA2884592C
(en)
|
2012-09-19 |
2021-08-31 |
Grespo Ab |
Compositions for improvement of brain function
|
|
CN102976927A
(zh)
*
|
2012-12-26 |
2013-03-20 |
天津天成制药有限公司 |
α-酮戊二酸钙的制备方法
|
|
CA2896646A1
(en)
|
2012-12-27 |
2014-07-03 |
Hayashibara Co., Ltd. |
Skin-exterior anti-ageing composition and production method therefor
|
|
US20150328176A1
(en)
|
2013-01-25 |
2015-11-19 |
Winning The Fight Inc. |
Composition for treatment of neurodegenerative disease
|
|
US9511057B2
(en)
|
2013-03-15 |
2016-12-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating denervation-induced muscle atrophy
|
|
KR102499654B1
(ko)
|
2013-03-19 |
2023-02-13 |
유니버시티 오브 사우스 플로리다 |
상승되고 지속되는 케톤증을 생성하기 위한 조성물 및 방법
|
|
US20160263092A1
(en)
|
2013-12-19 |
2016-09-15 |
Twi Biotechnology, Inc. |
Therapeutic uses of berberine formulations
|
|
KR20160111529A
(ko)
|
2014-02-12 |
2016-09-26 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
노화 및 연령 관련 질환 및 증상의 치료를 위한 조성물 및 방법
|
|
WO2015171723A1
(en)
|
2014-05-06 |
2015-11-12 |
Research Development Foundation |
Methods for treating insulin resistance and for sensitizing patients to glp1 agonist therapy
|
|
CN106659701B
(zh)
|
2014-06-30 |
2021-04-27 |
加尼福尼亚大学董事会 |
用于治疗年龄相关性症状和疾病的酮基丁酸酯化合物和组合物
|
|
IL282156B
(en)
|
2014-07-29 |
2022-07-01 |
Shenzhen Hightide Biopharmaceutical Ltd |
Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof
|
|
WO2016019224A1
(en)
|
2014-07-31 |
2016-02-04 |
Indiana University Research And Technology Corporation |
Antithetical regulation of endothelial ace and ace2 by brg1-foxm1 complex underlies pathological cardiac hypertrophy
|
|
CN104529755B
(zh)
*
|
2014-12-29 |
2016-01-06 |
精晶药业股份有限公司 |
一种从转化液中分离α-酮戊二酸的方法
|
|
SG11201708030XA
(en)
|
2015-04-06 |
2017-10-30 |
Shenzhen Hightide Biopharmaceutical Ltd |
Conjugate compounds of ursodeoxycholic, berberine or l-carnitine, and compositions and methods thereof
|
|
JP2018517774A
(ja)
|
2015-06-10 |
2018-07-05 |
エリジウム・ヘルス・インコーポレイテッド |
ニコチンアミドリボシドおよびプテロスチルベン組成物ならびに皮膚障害の処置のための方法
|
|
US20180193458A1
(en)
|
2015-07-08 |
2018-07-12 |
Unity Biotechnology, Inc. |
Compositions and methods for treating senescence-associated diseases and disorders
|
|
EP3518915A4
(en)
|
2016-09-30 |
2020-04-15 |
The Regents of the University of California |
ALPHA KETOBUTYRATE, ALPHA KETOGLUTARATE AND 2-HYDROXYBUTYRATE FOR STIMULATING HAIR GROWTH
|
|
PL231635B1
(pl)
|
2017-01-03 |
2019-03-29 |
Politechnika Poznanska |
Sposób produkcji kwasu alfa-ketoglutarowego (AKG) z jednoskładnikowych roztworów wodnych
|
|
MX2017004010A
(es)
|
2017-03-27 |
2018-02-09 |
Antonio Hernandez Miramontes Jorge |
Mezcla de oxalacetato, alfacetoglutarato, ácido tartánico y sales de lactato de calcio y sodio, para tratar pacientes con insuficiencia renal crónica.
|
|
SG10202107237SA
(en)
|
2017-04-25 |
2021-08-30 |
Buck Inst Res Aging |
Formulations for extending lifespan and healthspan
|
|
US20200253907A1
(en)
|
2017-08-21 |
2020-08-13 |
The Regents Of The University Of California |
Compositions and Methods for Treating Neurodegenerative Diseases
|
|
KR102833111B1
(ko)
|
2018-09-25 |
2025-07-10 |
폰세 드 리온 헬스 데지그네이티드 액티비티 컴퍼니 |
칼슘 알파-케토글루타레이트의 제조 방법
|
|
WO2020086733A1
(en)
|
2018-10-24 |
2020-04-30 |
Ponce De Leon Health Designated Activity Company |
Nicotinamide riboside compositions for healthspan extension
|
|
US20220265586A1
(en)
*
|
2019-06-10 |
2022-08-25 |
Ponce De Leon Health Designated Activity Company |
Sustained-release compositions of alpha-ketoglutarate
|
|
CN114126599A
(zh)
|
2019-06-10 |
2022-03-01 |
巴克老龄化研究所 |
改变衰老相关分泌表型的方法和组合物
|
|
CA3188646A1
(en)
|
2020-07-02 |
2022-01-06 |
Ponce De Leon Health Designated Activity Company |
Compositions and methods for treating crp-mediated diseases
|
|
CN112941116B
(zh)
*
|
2021-01-04 |
2022-12-02 |
上海朴颐化学科技有限公司 |
一种酶法制备α-酮戊二酸钙的方法
|
|
CN115974679A
(zh)
*
|
2022-12-20 |
2023-04-18 |
绍兴市精益生物化工有限公司 |
α-酮戊二酸钙盐制备方法
|